Navigation Links
Melanoma Less Common in Blacks But Deadlier
Date:12/23/2009

Skin cancer diagnosis occurs later in nonwhites, study finds

WEDNESDAY, Dec. 23 (HealthDay News) -- Doctors are diagnosing more white people with the deadly skin cancer known as melanoma, and while Hispanics and blacks are much less likely to be diagnosed with the malignancy, they often have advanced forms of the cancer when it is found, new research suggests.

"Research and public education efforts have focused on melanoma prevention in white populations because of their higher risk of developing melanoma," the study authors wrote in the December issue of the Archives of Dermatology. "Improved secondary prevention measures with earlier detection of thin [early-stage] melanoma likely account for the improved survival among whites from 68 percent in the early 1970s to 92 percent in recent years. Such advances, however, have not occurred in other racial and ethnic groups in the United States."

Researchers from the University of Miami Miller School of Medicine looked at statistics regarding 41,072 cases of melanoma between 1990 and 2004 from the Florida Cancer Data System. Almost all -- 39,670 -- were in non-Hispanic whites, with 1,148 in white Hispanics and 254 in blacks.

The Hispanic and black patients, however, had more advanced cases of melanoma, the study authors found. Eighteen percent of Hispanics and 26 percent of blacks had the most advanced kinds of cases, compared to 12 percent among non-Hispanic whites.

"Melanoma among darker-skinned populations has received little attention, partly reflecting their overall lower risk compared with white non-Hispanics," the authors noted. "The lowest survival rates and delayed melanoma diagnosis is often seen in blacks. With the readily expanding population and increasing melanoma rate of 2.9 percent per year, melanoma among Hispanics also becomes an increasingly important public health issue."

"This study adds to a growing body of literature that identifies a pervasive and persistent disparity in the stage of melanoma diagnosis between Hispanic and black patients versus white patients," wrote the authors of a commentary accompanying the study.

More information

Learn more about melanoma from the U.S. National Cancer Institute.



-- Randy Dotinga



SOURCE: JAMA/Archives journals, news release, Dec. 21, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Melanoma Diagnosis Often Delayed for Rural Poor
2. Melanoma drug revs immune cells but cancer cells ignore it
3. Promising drug combination may help those with ocular melanoma that has spread
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
6. New type of drug shows promise in attacking melanoma in an innovative way
7. Genes Unlock New Treatments for Deadly Melanoma
8. Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
9. Researchers Hone in on Cancer Stem Cells for Melanoma
10. Melanomas may appear noticeably different than other moles
11. Melanomas Present Unique Appearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® ... no longer use or need, from clothes to couches to dressers and bicycles. Roadie ... take them to the nearest Goodwill donation center through February 28th. , “January ...
(Date:1/20/2017)... ... 20, 2017 , ... Doctor C LLC, a company based out of Arizona ... to continue the marketing and distribution of its product, The Right C. , The ... better absorption than traditional vitamin C supplements. At the trade show, Doctor C had ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, ... everyday lives, recently attended the January ECRM Trade Show in Hilton Head, SC, ... for its large range of supplements that keep the body functioning at its ...
(Date:1/20/2017)... Viejo, California (PRWEB) , ... January 20, 2017 , ... ... easy to use inside of Final Cut Pro X," said Christina Austin - CEO ... on the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest tale ... each of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, ... City, and impassioned writer. , When asked of her new book, Marjorie says, “‘The ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
(Date:1/20/2017)... , Jan 20, 2017 Research and ... Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c ... End-use, And Segment Forecasts, 2013 - 2024" report to their ... The ... billion by 2024 Introduction of innovative solutions on the ...
Breaking Medicine Technology: